Success Metrics

Clinical Success Rate
85.7%

Based on 30 completed trials

Completion Rate
86%(30/35)
Active Trials
2(4%)
Results Posted
33%(10 trials)
Terminated
5(10%)

Phase Distribution

Ph phase_1
13
26%
Ph phase_4
9
18%
Ph phase_2
9
18%
Ph not_applicable
13
26%
Ph phase_3
5
10%

Phase Distribution

13

Early Stage

9

Mid Stage

14

Late Stage

Phase Distribution49 total trials
Phase 1Safety & dosage
13(26.5%)
Phase 2Efficacy & side effects
9(18.4%)
Phase 3Large-scale testing
5(10.2%)
Phase 4Post-market surveillance
9(18.4%)
N/ANon-phased studies
13(26.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.1%

30 of 37 finished

Non-Completion Rate

18.9%

7 ended early

Currently Active

2

trials recruiting

Total Trials

50

all time

Status Distribution
Active(5)
Completed(30)
Terminated(7)
Other(8)

Detailed Status

Completed30
unknown8
Terminated5
Withdrawn2
Not yet recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
50
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 113 (26.5%)
Phase 29 (18.4%)
Phase 35 (10.2%)
Phase 49 (18.4%)
N/A13 (26.5%)

Trials by Status

withdrawn24%
terminated510%
unknown816%
not_yet_recruiting24%
completed3060%
enrolling_by_invitation12%
recruiting24%

Recent Activity

Clinical Trials (50)

Showing 20 of 50 trialsScroll for more
NCT07394725Phase 1

Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

Completed
NCT06396078Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Recruiting
NCT06948747Phase 1

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Completed
NCT06273891Phase 3

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes

Recruiting
NCT06917872Phase 1

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Completed
NCT06461429Not Applicable

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Not Yet Recruiting
NCT01556334Phase 3

Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes

Withdrawn
NCT06574204

Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides

Not Yet Recruiting
NCT03024879Phase 4

The Effect of Motilin on the Frequency and Amount of Food Intake

Enrolling By Invitation
NCT06395610Phase 1

Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Completed
NCT03060473Phase 3

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

Terminated
NCT05995249Phase 1

A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

Completed
NCT04665089Not Applicable

Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact

Completed
NCT01569633Not Applicable

Use of Prokinetics in Early Enteral Feeding in Preterm Infants

Withdrawn
NCT00021671Phase 3

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

Completed
NCT04714554Phase 1

A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

Completed
NCT03480243Phase 1

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

Completed
NCT02017379Not Applicable

Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.

Terminated
NCT01342198Phase 1

An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet

Completed
NCT03966066Not Applicable

Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
50